Exclusive Summary

• • Dual-target synergy to overcome tumor heterogeneity.
• • Significantly superior to other single-target ADCs.
• • Innovatively designed, stable, hydrophilic and cleavable Exatecan-based linker-payload.

Asset Materials

Contact Us for Full Materials